Fennec Pharmaceuticals Inc.

(FRX:CA)

By |

Profile

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidates consist of COG ACCL0431 and SIOPEL 6.

Contact Information

Website: www.fennecpharma.com
Email: info@fennecpharma.com
Main Phone: +1 919 636-4530
Address: 68 TW Alexander Drive
Address 2: P.O Box 13628
State: NC
City / Town: Research Triangle Park
Country: USA
Postal Code: 27709

Issuer Information

Exchange: TSX
CEO: Rostislav Raykov
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 8.22 $ 0.10 (1.23%)
Last Price 8.22 Change $ 0.10 Change % 1.23 Tick N/A
Bid 8.01 Bid Size 100.00 Ask 8.31 Ask Size 100.00
Open 8.18 High 8.90 Low 8.05 Prev Close 8.12
Last Trade Volume 1,900 52 Wk Hi 18.86 52 Wk Low 7.90
Market Cap 157 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,104,164.00 EPS (TTM) -0.68 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 23.24 23.24 23.24 23.24
Low Target Price Estimate 21.82 21.82 21.82 21.82
Mean Target Price Estimate 22.53 22.53 22.53 22.53
Standard Deviation 1 1 1 1
Date of Most Recent Estimate 04/02/18 04/02/18 04/02/18 04/02/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1